Table 3.
List of 10 genes involved in pathways in cancer. These SM-induced alterations of expression were abolished or attenuated by MSTF treatment.
| Gene ID | Symbol | Description | Fold Change | |
|---|---|---|---|---|
| SM | SM + MSTF | |||
| 691155 | Ccdc6 | coiled-coil domain containing 6 | 1.66 | 1.32 |
| 58919 | Ccnd1 | cyclin D1 | 0.56 | 0.73 |
| 24337 | Erbb2 | v-erb-b2 avian erythroblastic leukemia viral oncogene 2 | 0.6 | 0.69 |
| 25163 | Cdkn2a | cyclin-dependent kinase inhibitor 2A | 1.67 | 1.19 |
| 170579 | Fgf22 | fibroblast growth factor 22 | 1.74 | 1.21 |
| 84489 | Fgfr3 | fibroblast growth factor receptor 3 | 2.35 | 0.9 |
| 114517 | Itga6 | integrin, α 6 | 1.51 | 1.08 |
| 24516 | Jun | jun proto-oncogene | 0.64 | 0.67 |
| 25682 | Ppard | peroxisome proliferator-activated receptor δ | 1.57 | 0.88 |
| 363595 | Tcf7 | transcription factor 7 (T-cell specific, HMG-box) | 1.68 | 1.02 |